1. FRI0110 Assessment of Immunogenicity of Live Zoster Vaccination in Rheumatoid Arthritis Patients on Background Methotrexate before and after Initiating Tofacitinib or Placebo. (15th July 2016) Authors: Winthrop, K.; Wouters, A.; Choy, E.; Soma, K.; Hodge, J.; Nduaka, C.; Biswas, P.; McNeil, L.; Passador, S.; Mojcik, C.; Rigby, W. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0174 Analysis of Non-melanoma Skin Cancer Across the Tofacitinib Rheumatoid Arthritis Clinical Programme. (9th June 2015) Authors: Curtis, J.; Lee, E.B.; Martin, G.; Mariette, X.; Terry, K.; Chen, Y.; Geier, J.; Andrews, J.; Kaur, M.; Fan, H.; Nduaka, C. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0595 Changes in serum creatinine in patients with active rheumatoid arthritis treated with TOFACITINIB (CP-690, 550). (23rd January 2014) Authors: Isaacs, J.; Nduaka, C.; Zuckerman, A.; Krishnaswami, S.; Riese, R.; Lan, S.; Hutmacher, M.; Boy, M.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0145 Association of Mean Changes in Laboratory Safety Parameters with C-Reactive Protein at Baseline and Week 12 in Rheumatoid Arthritis Patients Treated with Tofacitinib. (10th June 2014) Authors: Strand, V.; Isaacs, J.; Beal, J.; Nduaka, C.; Krishnaswami, S.; Riese, R.; Boy, M.; Menon, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0179 Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-label, Long-term Extension up to 6 Years. (9th June 2015) Authors: Wollenhaupt, J.; Silverfield, J.; Lee, E.B.; Wood, S.P.; Terry, K.K.; Nakamura, H.; Kwok, K.; Anisfeld, A.; Nduaka, C.; Wang, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0185 Tofacitinib, An Oral JAK Inhibitor, in The Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years. (15th July 2016) Authors: Wollenhaupt, J.; Silverfield, J.; Lee, E.B.; Terry, K.K.; Kwok, K.; Lazariciu, I.; Nduaka, C.; Connell, C.A.; DeMasi, R.; Wang, L. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0192 Evaluating Pharmacokinetic Predictors of Tofacitinib Clinical Response in Rheumatoid Arthritis. (15th July 2016) Authors: Lamba, M.; Furst, D.; Dikranian, A.; Dowty, M.; Hutmacher, M.; Conrado, D.; Stock, T.; Nduaka, C.; Krishnaswami, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety evaluation of Acalypha wilkesiana in albino rats and BHK-21 cell line. (May 2016) Authors: Makoshi, M.; Oladipo, O.; Gotep, J.; Forcados, G.; Shu, M.; Chinyere, C.; Yusuf, H.; Akanbi, B.; Samuel, A.; Ozele, N.; Dogonyaro, B.; Atiku, A.; Ahmed, M.; Nduaka, C. Journal: Comparative clinical pathology Issue: Volume 25:Number 3(2016) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗